# Immunomodulators on HIV-1 Reservoir

> **NCT05598580** · PHASE4 · UNKNOWN · sponsor: **First Affiliated Hospital of Zhejiang University** · enrollment: 48 (estimated)

## Conditions studied

- HIV Infections

## Interventions

- **DRUG:** Lenalidomide
- **DRUG:** Adenosylmethionine

## Key facts

- **NCT ID:** NCT05598580
- **Lead sponsor:** First Affiliated Hospital of Zhejiang University
- **Sponsor class:** OTHER
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** 2022-11-20
- **Primary completion:** 2024-05
- **Final completion:** 2024-11
- **Target enrollment:** 48 (ESTIMATED)
- **Last updated:** 2023-09-14


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT05598580

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT05598580, "Immunomodulators on HIV-1 Reservoir". Retrieved via AI Analytics 2026-05-28 from https://api.ai-analytics.org/clinical/NCT05598580. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*